Trial intelligence / Profile preview

VICToRY Pilot Trial – High-dose Intravenous Vitamin C in Severe Burns

2020-000147-31Phase 2Active

Sponsor
Clinical Evaluation Research Unit
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ascorbic acid in burn injury, sponsored by Clinical Evaluation Research Unit. Primary endpoint: Feasibility metrics including compliance with the study protocol. Started Sep 2022; status: active.

02

Drugs

ascorbic acid
03

Conditions

burn injury

Beyond the preview

Go deeper on 2020-000147-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-000147-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call